Availability of anticancer biosimilars in 40 countries.
Huang HY, Wu DW, Ma F, Liu ZL, Shi JF, Chen X, Wang SH, Fang H, Bai Y, Yu Y, Fang Y, Sun C, Fan Q, Wu Y, Fan RH, Zhou CY, He BX, Dai M, Li N, Xu BH, Sun Y, He J.
Huang HY, et al. Among authors: wu y, wu dw.
Lancet Oncol. 2020 Feb;21(2):197-201. doi: 10.1016/S1470-2045(19)30860-5.
Lancet Oncol. 2020.
PMID: 32007192
No abstract available.